Loading clinical trials...
Loading clinical trials...
Remibrutinib in Real-world Clinical Practice: a Prospective, Multi-country, Non-interventional, Effectiveness and Safety Study
Conditions
Locations
1
United States
Cleaver Dermatology
Kirksville, Missouri, United States
Start Date
February 2, 2026
Primary Completion Date
October 30, 2031
Completion Date
October 30, 2031
Last Updated
April 16, 2026
NCT06931405
NCT06873516
NCT07230418
NCT07219615
NCT07021495
NCT05677451
Novartis Pharmaceuticals
CONTACT
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions